Abstract
Very few of the genes that are important in pituitary tumor initiation, progression, and metastasis have been identified to date. To identify potential genes that may be important in pituitary tumor progression and carcinoma development, we used AffymetrixTM GeneChip HGU-133A-oligonucleotide arrays, which contain more than 15,000 characterized genes from the human genome to study gene expression in an ACTH pituitary carcinoma metastatic to the liver and four pituitary adenomas. Reverse-transcriptase real-time quantitative-PCR (RT-qPCR) was then used to analyze 4 nonneoplastic pituitaries, 19 adenomas, and the ACTH carcinoma. A larger series of pituitary adeno mas and carcinomas were also analyzed for protein expression using tissue microarrays (TMA) (n=233) and by Western blotting (n=18). There were 4298 genes that were differentially expressed among the adenomas compared to the carcinoma, with 2057 genes overexpressed and 2241 genes underexpressed in the adenomas. The betagalacioside binding protein galactin-3 was underexpressed in some adenomas compared to the carcinomas. Prolactin (PRL) and ACTH tumors had the highest levels of expression of galectin-3. The human achaetescute homolog-1 ASCL1 (hASH-1) gene was also underexpressed in some adenomas compared to the carcinoma. Prolactin and ACTH tumors had the highest levels of expression of hASH-1. ID2, which has an important role in cell development and tumorigenesis, was underexpressed in some adenomas compared to the carcinomas. Transducin-like enhancer of split four/Croucho (TLE-4) was over-expressed in adenomas compared to the ACTH carcinoma. The differential expression of these genes was validated by RT-qPCR, by immunohistochemistry using TMA and by Western blotting. These results indicate that the LGALS3, hASH1, ID2, and TLE-4 genes may have important roles in the development of pituitary carcinomas.
Similar content being viewed by others
References
Asa, S. L. and Ezzat, S. (2002). Nat. Rev. Cancer 2, 836–849.
Landis, C. A., Masters, S. B., Spada, A., Pace, A. M., Bourne, H. R., and Vallar, L. (1989). Nature 340, 692–6961.
Pei, L. and Melmed, S. (1997). Mol. Endocrinol. 11, 433–441.
Zhang, X., Sun, H., Danila, D. C., et al (2002). J. Clin. Endocrinol. Metab. 87, 1262–1267.
Zhang, X., Zhou, Y., Mehta, K. R., et al. (2003). J. Clin. Endocrinol. Metab. 88, 5119–5126.
Lloyd, R. V. (2001). J. Neurooncol. 54, 111–119.
Levy, A. and Lightman, S. (2003). Front. Neuroendocrinol. 24, 94–127.
Woloschak, M., Yu, A., Xiao, J., and Post, K. D. (1996). Cancer Res. 56, 2493–2496.
Simpson, D. J., Clayton, R. N., and Farrell, W. E. (2003). Oncogene 21, 1217–1224.
Simpson, D. J., Hibberts, N. A., McNicol, A. M., Clayton, R. N., and Farrell, W. E. (2000). Cancer Res. 60, 1211–1216.
Riss, D., Jin, L., Qian, X., et al. (2003). Cancer Res. 63, 2251–2255.
Ruebel, K. H., Jin, L., Qian, X., et al. (2005). Cancer Res. 65, 1136–1140.
Qian, Z. R., Sano, T., Yoshimoto, K., et al. (2005). Lab. Invest. 85, 464–473.
Zhao, J., Dahle, D., Zhou, Y., Zhang, X., and Klibanski, A. (2005). J. Clin. Endocrinol. Metab. 90, 2179–2186.
Zhang, X., Horwitz, G. A., Heaney, A. P., et al. (1999). J. Clin. Endocrinol. Metab. 84, 761–767.
Ishikawa, H., Heaney, A. P., Yu, R., Horwitz, G. A., and Melmed, S. (2001). J. Clin. Endocrinol. Metab. 86, 867–874.
Pernicone, P. J., Scheithauer, B. W., Sebo, T. J., et al. (1997). Cancer 79, 804–812.
Scheithauer, B. W., Kurtkaya-Yapicier, O., Kovacs, K. T., Young W. F. Jr., and Lloyd, R. V. (2005). Neurosurgery 56, 1066–1074; discussion 1066–1074.
Kaltsas, G. A., Nomikos, P., Kontogeorgos, G., Buchfelder, M., and Grossman, A. B. (2005). J. Clin. Endocrinol. Metab. 90, 3089–3099.
Pei, L., Melmed, S., Scheithauer, B., Kovacs, K., and Prager, D. (1994). J. Clin. Endocrinol. Metab. 78, 842–846.
Yu, R. and Melmed, S. (2001). Brain Pathol. 11, 328–341.
Herman, V., Drazin, N. Z., Gonsky, R., and Melmed, S. (1993). J. Clin. Endocrinol. Metab. 77, 50–55.
Goidin, D., Kappeler, L., Perrot, J., Epelbaum, J., and Gourdji, D. (2000). Endocrinology 141, 4805–4808.
Wood, W. M., Sarapura, V. D., Dowding, J. M., et al. (2002). Endocrinology 143, 347–359.
Mohammad, H. P., Seachrist, D. D., Quirk, C. C., and Nilson, J. H. (2004). Mol. Endocrinol. 18, 2583–2593.
Evans, C. O., Young, A. N., Brown, M. R., et al. (2001). J. Clin. Endocrinol. Metab. 86, 3097–3107.
Tanaka, S., Tatsumi, K., Okubo, K., et al. (2002). J. Mol. Endocrinol. 28, 33–44.
Morris, D. G., Musat, M., Czirjak, S., et al. (2005). Eur. J. Endocrinol. 153, 143–151.
Woo, Y., Affourtit, J., Daigle, S., et al. (2004). J. Biomol. Tech. 15, 276–284.
Tan, P. K., Downey, T. J., Spitznagel, E. L. Jr., et al. (2003). Nucleic Acids Res. 31, 5676–5684.
Barondes, S. H., Cooper, D. N., Gitt, M. A., and Leffler, H. (1994). J. Biol. Chem. 269, 20807–20810.
Amado, M., Almeida, R., Schwientek, T., and Clausen, H. (1999). Biochim. Biophys. Acta 1473, 35–53.
Furukawa, K. and Sato, T. (1999). Biochim. Biophys. Acta 1473, 54–66.
Ochieng, J., Fridman, R., Nangia-Makker, P., et al. (1994). Biochemistry 33, 14109–14114.
Nangia-Makker, P., Honjo, Y., Sarvis, R., et al. (2000). Am. J. Pathol. 156, 899–909.
Yoshii, T., Fukumori, T., Honjo, Y., Inohara, H., Kim, H. R., and Raz, A. (2002). J. Biol. Chem. 277, 6852–76857.
Bresalier, R. S., Mazurek, N., Sternberg, L. R., et al. (1998). Gastroenterology 115, 287–296.
Xu, X. C., el-Naggar, A. K., and Lotan, R. (1995). Am. J. Pathol. 147, 815–822.
Jin, L., Riss, D., Ruebel, K. H., et al. (2005). Endocr. Pathol. 16, 104–114.
Salameh, B. A., Leffler, H., and Nilsson, U. J. (2005). Bioorg. Med. Chem. Lett. 15, 3344–3346.
Guillemot, F., Lo, L. C., Johnson, J. E., Auerbach, A., Anderson, D. J., and Joyner, A. L. (1993). Cell 75, 463–476.
Lo, L., Guillemot, F., Joyner, A. L., and Anderson, D. J. (1994). Perspect. Dev. Neurobiol. 2, 191–201.
Shida, T., Furuya, M., Nikaido, T., et al. (2005). Clin. Cancer Res. 11, 450–458.
Linnoila, R. I., Naizhen, X., Meuwissen, R., Berns, A., and DeMayo, F. J. (2005). Exp. Lung. Res. 31, 37–55.
Ferretti, E., Di Stefano, D., Zazzeroni, F., et al. (2003). J. Endocrinol. Invest. 26, 957–965.
Jiang, S. X., Kameya, T., Asamura, H., et al. (2004). Mod. Pathol. 17, 222–229.
Ruzinova, M. B. and Benezra, R. (2003). Trends Cell Biol. 13, 410–418.
Sikder, H. A., Devlin, M. K., Dunlap, S., Ryu, B., and Alani, R. M. (2003). Cancer Cell 3, 525–530.
Yokota, Y. and Mori, S. (2003). J. Cell Physiol. 190, 21–28.
Kowanetz, M., Valcourt, U., Bergstrom, R., Heldin, C. H., and Moustakas, A. (2004). Mol. Cell Biol. 24, 4241–4254.
Chen, G. and Courey, A. J. (2000). Gene 249, 1–16.
Gasperowicz, M. and Otto, F. (2005). J. Cell Biochem. 95, 670–687.
Dasen, J. S., Barbera, J. P., Herman, T. S., et al. (2001). Genes Dev. 15, 3193–3207.
Douglas, K. R., Brinkmeier, M. L., Kennell, J. A., et al. (2001). Mamm. Genome 12, 843–851.
Brinkmeier, M. L., Potok, M. A., Cha, K. B., et al. (2003). Mol. Endocrinol. 17, 2152–2161.
Moreno, C. S., Evans, C. O., Shan, X., Okor, M., Desideno, D. M., and Oyesiku, N. M. (2005). Cancer Res. 65, 10214–10222.
Kobayashi, I., Jin, L., Ruebel, K. H., Bayliss, J. M., Hidehiro, O., and Lloyd, R. V. (2003). Endocrine 22, 285–292.
Horiguchi, H., Jin, L., Ruebel, K. H., Scheithauer, B. W., and Lloyd, R. V. (2004). Endocrine 24, 141–156.
Mhawech, P., Berczy, M., Assaly, M., et al. (2004). Ant. J. Clin. Pathol. 122, 100–105.
Dang, J., Inukai, T., Kurosawa, H., et al. (2001). Mol. Cell Biol. 21, 5935–5945.
Jin, L., Zhang, S., Bayliss, J., et al. (2003). Endocr. Pathol. 14, 37–48.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ruebel, K.H., Leontovich, A.A., Jin, L. et al. Patterns of gene expression in pituitary carcinomas and adenomas analyzed by high-density oligonucleotide arrays, reverse transcriptase-quantitative PCR, and protein expression. Endocr 29, 435–444 (2006). https://doi.org/10.1385/ENDO:29:3:435
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:29:3:435